MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Identifying key symptoms associated to parkinsonism other than Parkinson’s Disease: a case series

    M. Gaitan-Palau, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: This study aims to identify the main symptoms associated with the clinical diagnosis of parkinsonism, excluding Parkinson's disease (PD), among patients evaluated by non-specialist…
  • 2024 International Congress

    The Differences in the Perception of Parkinson’s Disease-related Motor Complications between Patients and Physicians

    T. Tezuka, R. Okochi, Y. Sakai, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: This study aimed to evaluate the differences in the perception of Parkinson’s disease (PD)-related motor complications by utilizing questionnaires answered by both PD patients…
  • 2024 International Congress

    The Impact of Parkinson’s Disease on Causal Perception

    Z. Rostami, M. Vaziri Pashkam, M. Salari (Tehran, Islamic Republic of Iran)

    Objective: Investigating the visual causality perception in Parkinson's disease (PD) patients and comparing their performance with that of healthy individuals. Background: Parkinson’s disease (PD) is…
  • 2024 International Congress

    The Prevalence of Parkinson’s Disease with Dementia in a door to door survey done in a rural district in Hai, Kilimanjaro.

    E. Assey, R. Morton, J. Josephat, R. Valecha (Kilimanjaro, United Republic of Tanzania)

    Objective: To determine the prevalence of dementia in persons living with Parkinson's disease in a door to door survey. Background: Research suggests that up to…
  • 2024 International Congress

    Non-motor Symptoms and Quality-of-life of People with Parkinson’s disease

    K. Prakash, X. Xiao, EC. Lim (Singapore, Singapore)

    Objective: To assess the association between non-motor symptoms and quality of life of people with Parkinson's disease of different motor subtypes. Background: Little is known…
  • 2024 International Congress

    Perspective of people living with early Parkinson’s Disease: most common, burdensome, and worrisome symptoms

    S. Messner, T. Carmody, R. Park, B. Jones, A. Hursey, E. Lucassen (Basel, Switzerland)

    Objective: To assess the most common, burdensome and worrisome symptoms experienced by people living with early Parkinson’s Disease (ePD). Background: Research on symptom frequency and…
  • 2024 International Congress

    Evaluating the Impact of the Pain Self-Management Program in PD

    A. Zawar (Lynnwood, USA)

    Objective: The program aims to provide PD individuals with skill sets, knowledge, and tools necessary to effectively self-manage their pain through non-pharmacological approaches. By empowering…
  • 2024 International Congress

    Parkinson’s disease biomarkers in human olfactory cleft mucus

    J. Morley, N. Cohen, S. Koganti, S. Wood, H. Wang (Philadelphia, USA)

    Objective: To investigate and identify biomarkers for PD from human olfactory cleft mucus Background: Olfactory loss is an early symptom of PD, often preceding motor…
  • 2024 International Congress

    Deep learning-based Prediction of Visual Dysfunction in Parkinson’s Disease from 31 Brain Regions of Interest using Quantitative Diffusion MRI

    C. Raimondo, L. Singanamala, M. Alizadeh (Philadelphia, USA)

    Objective: Compare the performance of deep learning and machine learning models trained on quantitative diffusion measurements in the prediction of visual dysfunction in Parkinson’s Disease…
  • 2024 International Congress

    Dopamine Dysregulation in Parkinson’s Disease and Substance Use: Therapeutic Use and Compulsive Behaviors Thin Line

    J. Hall, R. Islam, D. Nolasco, B. Carr (GAINESVILLE, USA)

    Objective: Parkinson's Disease (PD) inherently disrupts dopaminergic transmission, primarily within the nigrostriatal pathway, necessitating dopaminergic therapies. However, these therapies can lead to Dopamine Dysregulation Syndrome…
  • « Previous Page
  • 1
  • …
  • 138
  • 139
  • 140
  • 141
  • 142
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley